MedTrace Logo

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

NCT02812576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-06-24

No results posted yet for this study

Summary

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require robust data. This study as the first national, multicenter study to investigate the epidemiology of GBS disease in China, and the resistance surveillance of GBS isolates, to appraise the necessity of appropriate interventions.

Conditions

  • Invasive Group B Streptococcal Disease

Sponsors & Collaborators

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Haiying Liu, MD, Ph.D · Guangzhou Women and Children's Medical Center

Eligibility

Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812576 on ClinicalTrials.gov